Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial
Dinutuximab Beta 联合替莫唑胺化疗治疗复发难治性神经母细胞瘤患儿：ITCC-SIOPEN BEACON II 期免疫试验结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01868
Gray, Juliet C; Weston, Rebekah; Owens, Cormac; Canete, Adela; Gambart, Marion; De Wilde, Bram; Nysom, Karsten; van Eijkelenburg, Natasha; Ladenstein, Ruth; Castellano, Aurora; Gerber, Nicolas U; Marshall, Lynley V; Barone, Giuseppe; Rubio-San-Simon, Alba; Ng, Antony; Vaidya, Sucheta; Gallego, Soledad; Makin, Guy; Burke, G A Amos; McCarthy, Anthony; Murphy, Dermot; Zwaan, C Michel; López-Almaraz, Ricardo; Jannier, Sarah; Thebaud, Estelle; Corradini, Nadege; Yeomanson, Dan; Howell, Lisa; Tweddle, Deborah A; Elliott, Martin; Hobin, Dave; Valteau-Couanet, Dominique; Schleiermacher, Gudrun; Chastagner, Pascal; Defachelles, Anne Sophie; Brichard, Benedicte; George, Sally; Chesler, Louis; Laidler, Jennifer; Firth, Charlotte; Holt, Grace; Moroz, Veronica; Pearson, Andrew D J; Gates, Simon; Wheatley, Keith; Kearns, Pam; Moreno, Lucas
